Overview

Donepezil Memory Preservation Post ECT

Status:
Terminated

Trial end date:
2017-03-24

Target enrollment:

Participant gender:

Summary

This randomized, placebo-controlled trial will evaluate the use of donepezil compared to placebo to reduce the risk of memory impairment after electroconvulsive therapy (ECT).

Phase:

N/A

Details

Lead Sponsor:

Porter Adventist Hospital

Treatments:

Donepezil